Sensus Healthcare Inc. (SRTS) reported steep declines in fourth-quarter 2025 results, with revenue falling to $4.9 million (down 62.2% year‑over‑year) and gross profit sliding to $1.9 million (down 73.29% year‑over‑year). Operating results swung deeper into loss, with operating profit of -$3.1 million (down 282.44% year‑over‑year) and net loss attributable to common shareholders of -$3.0 million (down 294.76% year‑over‑year). Diluted earnings per share were -$0.19 (down 290.0% year‑over‑year).
On the cash‑flow and balance‑sheet side, operating cash flow remained negative but improved versus the prior year, with cash used in operations of -$2.2 million (up 166.87% year‑over‑year). Capital expenditures were modest at -$158,000 (down 153.2% YoY). The company held $22.1 million in cash and cash equivalents (up 0.12% YoY) while total liabilities declined to $4.9 million (down 22.04% YoY).
Market reaction showed a modest intraday decline, with the stock down 3.86% since the market opened this morning.
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
Sensus Healthcare Inc. Insider Trading Activity
Sensus Healthcare Inc. insiders have traded $SRTS stock on the open market 6 times in the past 6 months. Of those trades, 6 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $SRTS stock by insiders over the last 6 months:
- JOSEPH C SARDANO (CHIEF EXECUTIVE OFFICER) purchased 25,000 shares for an estimated $100,750
- ERIC SACHETTA has made 3 purchases buying 11,500 shares for an estimated $46,380 and 0 sales.
- MICHAEL SARDANO (PRESIDENT AND GENERAL COUNSEL) has made 2 purchases buying 2,000 shares for an estimated $8,060 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Sensus Healthcare Inc. Hedge Fund Activity
We have seen 14 institutional investors add shares of Sensus Healthcare Inc. stock to their portfolio, and 28 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KINGSTONE CAPITAL PARTNERS TEXAS, LLC removed 668,880 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $2,100,283
- PERRITT CAPITAL MANAGEMENT INC removed 469,692 shares (-78.9%) from their portfolio in Q3 2025, for an estimated $1,474,832
- ACADIAN ASSET MANAGEMENT LLC removed 171,824 shares (-75.0%) from their portfolio in Q4 2025, for an estimated $683,859
- DIVISADERO STREET CAPITAL MANAGEMENT, LP removed 154,018 shares (-34.0%) from their portfolio in Q4 2025, for an estimated $612,991
- DIMENSIONAL FUND ADVISORS LP removed 125,673 shares (-22.1%) from their portfolio in Q4 2025, for an estimated $500,178
- PACIFIC RIDGE CAPITAL PARTNERS, LLC added 125,245 shares (+21.8%) to their portfolio in Q4 2025, for an estimated $498,475
- GSA CAPITAL PARTNERS LLP removed 71,696 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $225,125
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
